Word Weer Mens - Cookbook, Specialist Book, Health Book ... and Much More
more
Stories about Gesundheit
European Association of E-Pharmacies (EAEP)
EAMSP kicks off information campaign about digitization in German healthcare sector / Fighting the allergic reaction to anything new with #neuschnupfen
moreWorldwide first and only shotgun lipidomics service provider with official GMP certificate
Dresden / Germany (ots) - Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health - especially in the pharma industry. This is why quality ...
moreMundipharma EDO GmbH: US FDA Grants Orphan Drug Designation for Tinostamustine in Very Rare Blood Cancer
Basel, Switzerland (ots/PRNewswire) - FOR EX-US MEDICAL AND TRADE MEDIA ONLY - T-cell prolymphocytic leukaemia is an extremely rare and aggressive T-cell leukaemia, with very limited effective treatment options1,2 - Tinostamustine is in very early phase clinical trials to investigate it as a potential future ...
moreLEUKOCARE Announces Appointment of Dr Andreas Seidl as new Chief Operating Officer and member of the Executive Board
Munich, Germany (ots) - Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and regulatory, logistics and intellectual property of LEUKOCARE AG. He will assume his new role on April 1, 2019. Munich-based ...
moreCardiovascular diseases and nutrition in Europe: every second to third premature death preventable
more
Invisible self-disinfection: "wipe-on glass" enables permanent hygiene and protection from infection through creation of antimicrobial surfaces
moreSysmex Inostics' OncoBEAM(TM) platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers
Hamburg, Germany (ots) - Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups demonstrate the importance of a highly sensitive test for detection of clinically-relevant mutations present in circulating tumor DNA (ctDNA) derived ...
moreEuropean Society for Medical Oncology (ESMO)
Breast cancer patients use Twitter as a non-medical forum to share their experiences
Lugano/Munich (ots) - Twitter is a place where many cancer patients share and discuss their experiences, a study at the ESMO 2018 Congress reveals, based on analysis of the contents of over 6,000 tweets and retweets about breast cancer. The study was part of a larger, multidisciplinary project to observe the presence of different diseases on social media. The data ...
moreBritta Fuenfstueck appointed as new CEO of the HARTMANN GROUP
moreIndia hosts the Mahatma Gandhi International Sanitation Convention / 29th September to 2nd October 2018, New Delhi
New Delhi (ots) - Ministers and sanitation sector leaders from around the world will convene this month at the Mahatma Gandhi International Sanitation Convention (MGISC) in New Delhi. Hosted by the Government of India, this event will be an opportunity for delegates to exchange sanitation successes and best ...
moreEuropean Society for Medical Oncology (ESMO)
ESMO emphasises importance of cancer on global health agenda at WHA
Lugano (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100006433?langid=2 - At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide ...
more
Hitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe announces "ScanSync" - a new function for diagnostic ultrasound that reduces the burden on operators - which is to be supported by the "ARIETTA Prologue"
Vienna (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100012989?langid=2 - This function enables the operation of the diagnostic ultrasound system via auto detection of transducer movement. Hitachi Medical Systems Europe, a wholly owned subsidiary of Hitachi, ...
morePersonnel Change in Executive Board of L&R
Vienna/Rengsdorf (ots) - In January 2018, a change in the Executive Board of manufacturer and supplier of medical devices, Lohmann & Rauscher (L&R), took place after the former Chief Commercial Officer, Markus Sebastian, had resigned. The Advisory Board and the CCO mutually agreed that Markus Sebastian is going to leave the Lohmann & Rauscher Corporate Group by the end of January 2018 to pursue new tasks and face new ...
moreFresenius Medical Care AG & Co. KGaA
Fresenius Medical Care to acquire NxStage Medical, Inc. to strengthen its vertically integrated dialysis business
Bad Homburg (ots) - Acquisition of NxStage Medical, Inc. would: - position Fresenius Medical Care as a global leader in home dialysis - establish U.S. presence in the critical care space - further enhance clinical outcomes and patient empowerment - support strategic initiative of vertical integration and Care ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Aloka will present the ARIETTA V70*1 with enhanced Elastography functions
Tokyo, Japan (ots) - At this year's ECR (European Congress of Radiology), March 2-6 in Vienna, Hitachi Aloka will present ARIETTA V70*1 with enhanced Elastography functions. As the pioneer of Elastography, Hitachi Aloka Medical, Ltd. maintains its leadership in this field, providing solutions that can drive Elastography examinations to a new stage by equipping their ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Aloka launches two new, highly flexible Diagnostic Ultrasound Systems, ARIETTA Precision and ARIETTA Prologue
Tokyo, Japan (ots) - At this year's ECR (European Congress of Radiology), March 2-6 in Vienna, Hitachi Aloka Medical launches two new Diagnostic Ultrasound Systems, the ARIETTA Precision and the ARIETTA Prologue. The demand for diagnostic ultrasound examinations in healthcare areas such as advanced acute treatment, ...
moreEuropean Society for Medical Oncology (ESMO)
ESMO announces annual medical oncology congress platform in Europe from 2016
Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...
more
Boehringer Ingelheim's afatinib Achieves Primary Endpoint in Global Phase III Study in Recurrent/Metastatic Head and Neck Squamous Cell Cancer
Ingelheim, Germany (ots/PRNewswire) - - Results from the LUX-Head & Neck 1 study show afatinib* significantly delayed tumour growth versus chemotherapy in patients following failure of their previous treatment, reducing the risk for disease progression by 20% - Head and neck cancer has a very poor prognosis with no ...
moreDeutsche Gesetzliche Unfallversicherung (DGUV)
Publication of the programme for the World Congress on Safety and Health at Work 2014
Berlin (ots) - Top-level guests at the world's biggest safety & health convention - Day passes now bookable - Information for journalists A world without serious accidents at work - this is the vision that will be discussed by politicians, scientists and experts from all over the world at the XX World Congress on Safety and Health at Work, which is taking place in ...
moreOne Million DocCheckers / Europe's largest healthcare community reaches seven figures
Cologne (ots) - The DocCheck Community reached the magic number of one million users in April, putting it in a clear pole position among European healthcare communities. DocCheck has been providing GPs, consultants, students, pharmacists, nurses, pharmacy technicians and paramedics with healthcare-related news and services for more than 15 years. Launched in 1996 with ...
moreCGC Cramer-Gesundheits-Consulting GmbH
CYTONET SUBMITS EUROPEAN APPROVAL APPLICATION FOR LIVER CELL THERAPY TO TREAT UREA CYCLE DISORDERS IN CHILDREN
Weinheim/Germany (ots) - International biotechnology firm Cytonet announced today that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) seeking approval for its liver cell therapy for the treatment of Urea Cycle Disorders (UCD) in children. UCD is a life-threatening ...
moreDeutsche Gesetzliche Unfallversicherung (DGUV)
Last chance to submit contributions to the XX World Congress on Safety and Health at Work 2014
Berlin (ots) - The registration period for contributions to the XX World Congress on Safety and Health at Work 2014 ends on the 30th of November 2013. Participants who wish to make a contribution to a symposium are invited to submit an English-language summary thereof online at www.safety2014germany.com/papers. ...
moreBG ETEM - Berufsgenossenschaft Energie Textil Elektro Medienerzeugnisse
International Media Festival for Prevention: The best films for occupational safety and health will be awarded
Frankfurt (ots) - Films and multimedia applications are vital instruments of safety and health at work. Whether for the purpose of increasing risk awareness on the part of employees or providing information on comprehensive safety topics: moving images support the transfer of knowledge. Media makers have to keep ...
more
DocCheck goes India / DocCheck announces cooperation with India-based healthcare service
Cologne (ots) - Well-spread throughout Europe, DocCheck continues to expand into new markets. In order to provide healthcare professionals around the globe with its unique services, DocCheck has now settled an exclusive cooperation with Indian experts D2L Pharma Research Solutions. The cooperation encompasses the fast-growing healthcare market of India, thus granting ...
moreWorld Malaria Day: when a simple initiative conveys great results
Limburgerhof, Germany (ots) - - Interceptor® bed nets key factor for decrease in malaria infection in Jabote community (Brazil) - Positive spiral effect: less malaria, more kids in school - Cross reference: Pictures are available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/16344/basf_se/?keygroup=bild - April 25th marks the fourth annual celebration of World ...
moreBoehringer Ingelheim Initiates First Phase III Clinical Trial in Ovarian Cancer
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent[1], ...
moreFlibanserin Demonstrates Efficacy and Tolerability in Pivotal Phase III Trials in Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
Ingelheim, Germany, November 16 (ots/PRNewswire) - - Results Support Flibanserin as a Potential Treatment for HSDD, an Under-Recognised Women's Sexual Health Condition - For Medical Media, Outside the US Only Data from pooled, pivotal Phase III clinical trials demonstrate that flibanserin 100mg taken once daily at ...
moreBoehringer Ingelheim Receives Approval From the European Commission for Mirapexin(R)/Sifrol(R) Prolonged-Release, Once Daily Tablet for the Treatment of Parkinson's Disease
Ingelheim, Germany (ots/PRNewswire) - - New Formulation Brings the Established Efficacy of Mirapexin(R)/Sifrol(R) to Patients With Parkinson's Disease in the Convenience of a Once Daily Dose Boehringer Ingelheim today announced that the Mirapexin(R)/Sifrol(R) (pramipexole) new prolonged-release , once daily tablet ...
moreBoehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Pivotal Trials Programme for linagliptin
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Media Following the release of linagliptin Phase II data earlier this year, Boehringer Ingelheim has now announced the conclusion of the linagliptin pivotal Phase III clinical trials. The company confirmed that first results from the Phase III clinical ...
more
Previous12345678Next